News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seagen touts Adcetris early-stage Lymphoma data with 93% complete remission
Seattle-based biotech company Seagen appears to have found success with a drug in its phase II trials of early-stage classical Hodgkin lymphoma, with 93% of
A Day in the Life as a Bonum Therapeutics Principal Scientist
When Shannon Okada’s morning chai goes cold, it’s because she became immersed in her work in the lab. “We have a lot of fun solving
Grant programs announced for Washington life science startups
Life Science Washington Institute announced two new grant programs at its annual East West Summit. The grants will be used to fund life sciences startups
OtoNexus Medical Technologies ranks among Washington’s Best Workplaces
OtoNexus Medical Technologies, a Bellevue-based company, is among Puget Sound Business Journal’s “Washington’s 100 best workplaces.” OtoNexus is one of only 25 small companies –
Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal
Novartis announced that it will be purchasing Chinook Therapeutics, a Seattle-based biotech company, for $3.2 billion. Founded in 2019, Chinook Therapeutics focuses on developing treatments
Variant Bio turns focus from identifying genomic variants to drug discovery
Seattle-based biotech company Variant Bio will be creating new therapeutic programs to enhance its current research on genomic variants. The addition of Dr. David Moller
Seagen shareholders approve $43B acquisition by Pfizer
Seagen, a Bothell biotech company, is set to be acquired by Pfizer Pharmaceuticals following a shareholder vote on May 30. The $43 billion purchase is
A Home to Amazon, Starbucks, and Biotech Too
Biotech news organization Big4Bio invited journalist Luke Timmerman on its podcast to discuss Seattle’s growing biotech industry. Big4Bio amasses news on the four main biotech
Mozart Therapeutics adds $25M to earlier Series A round
Seattle-based biotech Mozart Therapeutics, which generates treatments for inflammatory and autoimmune diseases, has raised $25 million in funding. This investment follows an initial $55 million
Achieve Life Sciences raises $16.5M in pursuit of anti-smoking drug
Achieve Life Sciences (Achieve), a Bothell-based biotech company, has raised nearly $16.5 million. According to the company, the funding was secured through a registered direct
Cadence Neuroscience raises $26M to develop neural implants
Redmond-based startup Cadence Neuroscience raised $26 million in a Series B funding round that will be used toward finishing clinical studies and working on receiving
Cancer-focused biotech startup OncoResponse raises $27M
Seattle-based biotech startup OncoResponse raised $14 million in venture funding and a $13 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).